Compliance with the dialysis prescription
Adequacy of dialysis has a major impact on morbidity and mortality (2) . To achieve established targets of Kt/V and weekly creatinine clearance, the peritoneal dialysis (PD) prescription requires changes in daily dialysate volume, which in turn relates to volume and number of daily exchanges. Higher adequacy targets demand increased dialysate volume and an increased number of exchanges, as well as a combination of cycler and continuous ambulatory peritoneal dialysis (CAPD). One of the major obstacles to optimum dialysis, which can impair clinical outcome, is noncompliance with the dialysis prescription. In patients on PD, however, compliance is not easy to monitor, because the patients are performing lifesustaining therapy independently at home, for periods of up to two or three months, between clinic visits. The first major research into compliance with prescribed exchanges in PD treatment was done in the early 1990s, when Keen et al introduced a relatively simple method for detecting noncompliant patients (3) .
The method assumed that if the patient is performing regular dialysis, the ratio between measured and expected creatinine production should be approximately 1.0. Expected creatinine production is calculated from the Cockcroft and Gault formula, which takes into account age, sex, weight and serum creatinine level (4) .
If the patient is not performing all his exchanges, the serum creatinine level will rise to levels higher than if he were performing his dialysis prescription. As a result, when a 24 hour specimen of dialysate and urine is collected for adequacy studies (assuming that on the day of the test the prescribed number of exchanges will be performed), one will detect a "washout" effect. The amount of creatinine in the dialysate and urine will be higher than expected, leading one to overestimate the true creatinine production. As a consequence, the ratio between measured and expected creatinine will be higher than 1. According to the proponents of this method, a ratio exceeding 1.24 is an indication of noncompliance, and such patients should be investigated (3) .
Unfortunately, the initial enthusiasm for this "objective" method was not sustained, because a number of authors found this approach to be inaccurate. Although it was shown that a period of controlled noncompliance caused an increase in the ratio of measured to expected creatinine level (5) , the ratio did not exceed 1.0 in some severely malnourished patients, because of a low baseline creatinine excretion value. Thus these patients would not be identified as noncompliant (6) .
Furthermore others questioned the validity of this method on both theoretical (7) and experimental grounds (8) . Theoretical analysis, based on pharmacokinetics and a wide range in creatinine production, showed that a creatinine excretion ratio with a cut off of 1.24 was neither a sensitive nor a specific index of noncompliance (7) . In an effort to achieve experimental validation, Blake et al conducted a prospective clinical trial using a combination of: a) creatinine excretion ratio, b) the patients' own history of compliance (two questions asked by a nurse), and c) a period of four days of "ensured" compliance. Patients whose creatinine excretion ratio was high on the first day of the study continued to excrete higher than expected amounts of creatinine for the four consecutive days of observed or "ensured" compliance, not due to removal of excess creatinine but to constitutive high creatinine production related to relatively well preserved lean body mass (8) . This study concluded that the creatinine excretion ratio was an unreliable and nonspecific index of noncompliance. In an attempt to avoid some of the disadvantages of this method, Fisher at al measured the creatinine excretion ratio in three, consecutive, daily collections of dialysate and urine in a small group of patients (9) . The authors' assumptions were that during three consecutive days any "wash-out" effect would disappear, and that the creatinine excretion in dialysate and urine and the serum creatinine level would decrease. Noncompliance would be indicated by a decrease in the creatinine excretion ratio and serum creatinine level greater than 7.5% between day 1 and 3. The method identified noncompliance with a good specificity, but because it may not be sensitive enough to detect a low level of noncompliance and is complicated to perform, it has not proved clinically useful.
To summarise, noncompliance is just one of the reasons why measured/expected creatinine excretion ratio may change. Other reasons include changes in lean body mass, high dietary protein intake, acute changes in membrane permeability such as those that follow peritonitis, overcollection of urine or dialysate, collections of dialysate too close to a prescription change, and inaccurate assumptions about extra renal creatinine degradation. In addition, the estimate of expected creatinine excretion by the Cockroft-Gault formula may be inaccurate, because it was developed from data from persons with mild and moderate renal insufficiency and it does not address the contribution to creatinine generation by extra renal degradation and excretion (10) .
In an effort to develop new strategies to investigate compliance, the next studies focused on a check of used dialysate bags prescribed. Such studies defined noncompliance as the consumption of less than 90% of prescribed dialysate. This was measured in various ways. Fine at al did a retrospective chart review of the prescribed therapy and compared the result to records of dialysate delivered (11) .
They were able to show an excellent compliance; their method found 97% of patients to be compliant, compared to 78% (3) and 89% (6) in studies based on the creatinine excretion ratio. However, this method could not exclude the accumulation of unused bags in the patients' home. Another method was that of home inventory monitoring during two home visits by a nurse four to eight weeks apart (12) .
During this interval, exchanges performed during hospitalization days were subtracted from the prescribed dose, and all the supplies delivered to the patient between inventory visits were added to the initial inventory. The number of bags used between the two visits divided by the prescribed number of exchanges, expressed as percentage, represents the measure of compliance.
A third method of assessing patient compliance (monitoring the use of dialysis bags) was based on the Medication Event Monitoring System (MEMS). According to this approach, during two weeks of prospective observation, patients were asked to record exchange activities and to place the tabs from their used dialysis bags in the bottle closed with a MEMS cap (13) . Both home inventory measurement (12) and use of MEMS cups (13) detected non-compliance in around 40% of patients, definitely a much higher proportion than that reported by Fine at al based on chart reviews (11) .
It is worth mentioning however that the 40% rates on inventory monitoring and in MEMS studies were detected in US patients on PD, while the 3% noncompliance rate observed by Fine et al was in Canadian patients (11) . These results might be relevant to the CANUSA findings that the mortality rate in US patients was almost twice that in Canadian patients. Because all previous studies were done on relatively few patients (from 19 in MEMS study (13) to 121 in creatinine excretion ratio study (6) and because there was a large discrepancy among them, additional studies with a larger numbers of patients were needed. Thus, Blake et al developed a questionnairebased approach (14) .
In a large multicenter study of 656 patients, which included similar numbers of Canadian and US patients on PD, patients were asked to return an anonymous questionnaire regarding self-assessment of compliance with prescribed treatment regimen; in addition they were asked to provide information on demographic and social characteristics, which might be related to noncompliance. Using this approach, they found that a relatively low percentage (14%) of patients admitted to noncompliance.
Again, noncompliance was significantly more common among US (18%) than among Canadian (7%) patients.
Compliance with automated peritoneal dialysis
The techniques for the assessment of dialysis prescription compliance, noted above, focus on missed exchanges but did not record the duration and timing of Compliance with PD the exchanges. The latter event may be critical for patients on various forms of automated PD. The recent introduction of cycler machines that record treatment information, including quantity of dialysate used, duration of each dwell and time on the cycler will provide objective measure of compliance among these patients.
Compliance with medications and nutrition
Although significant efforts in compliance investigation have been made, we have not studied areas other than compliance with dialysis prescription. One such area is compliance with medication during PD treatment.
Bernardini et al have studied compliance with EPO treatment among 55 US patients (15) and found 55% noncompliance (use of less than 90% of prescribed EPO) among them. More research on this aspect of compliance is needed. Another important area for investigation is nutrition -an important but complex one.
Risk factors for noncompliance
Compliance may be affected by many confounding factors, such as age, sex, comorbidity, education, employment, and socioeconomic status of the individual. Noncompliance seems to be more common in CAPD than in automated PD patients (16) . In addition, patients prescribed more than four CAPD exchanges a day are more likely to be noncompliant (16) .
These findings are consistent with findings in diabetic patients, in whom compliance increases with reduction of the number of daily insulin injections (17) . Probably the most important demographic correlate of compliance is age. In both United States and Canadian PD patients, younger patients were more noncompliant than patients over 65 years (14) .
Patient compliance improves over the course of therapy for ESRD, and the same is true in PD patients (11, 18) . Few studies have assessed possible inter-relationships between psychological factors and indices of patient compliance in patients with ESRD. Social support, depression, and patient perceptions of their well being and quality of life may affect compliance with ESRD, particularly when they are on PD (19) . Up to now, except for a study from Italy (20) and one from Switzerland (9), all other studies have been performed in Canada and United States. Since it is possible that compliance may be related to various national characteristics it is desirable to do similar studies in other countries and such studies may contribute to international differences in PD outcome.
Correction of noncompliance
Research regarding compliance with medical therapy in PD patients consistently demonstrates that many patients fail to follow their physician's advice, fail to take medication as prescribed, and fail to appear for necessary medical appointments. Noncompliant patients have inadequate dialysis, an increase in hospitalized days, and a higher dropout rate (16) . For these reasons, we should identify risk factors and reasons for noncompliance and mount serious efforts to remove them. Patient education is essential to change compliance behaviors. Explanation of goals and responsibilities followed by a "contract" agreement between physician and patient, should increase compliance (21) .
Treatment plans should be realistic, based on what patients should and are capable of doing. We should stress that compliance assumes that the patient is told what to do, and is expected to faithfully and without question obey such instructions. Since patients spend only a small part of their lives in the physician's office, and doctors are not always at the center of their lives, we propose that patients be treated as intelligent autonomous people. Collaboration between patient and health care providers is central to the design of any treatment plan. An improved patient-health care provider interaction should be based on improved communication and a more active and voluntary role of patient in defining and pursuing goals of their medical treatment. Satisfaction with health-care providers is associated with improved compliance, supporting the importance of communication. Educational and continuous quality improvement programs can reduce the barriers to improved patient compliance and help to achieve the desired dialysis performance. B. B. STOJIMIROVIC 1 , P. G. BLAKE 2 , D. G. OREOPOULOS 1 
